ClinicalTrials.gov

A Web-based resource that provides patients, their family members, health care professionals, researchers, and the public with access to information… (More)

Topic mentions per year

Topic mentions per year

1980-2018
010002000300019802018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
BACKGROUND There is no evidence-based guidance to facilitate design decisions for confirmatory trials or systematic reviews… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 3
Is this relevant?
Review
2016
Review
2016
BACKGROUND Gastric cancer is the third most common cause of cancer-related mortality in the world. Currently there are two… (More)
  • figure 1
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND The ClinicalTrials.gov trial registry was expanded in 2008 to include a database for reporting summary results. We… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND An improvement in overall survival among patients with metastatic melanoma has been an elusive goal. In this phase 3… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND ClinicalTrials.gov is a publicly accessible, Internet-based registry of clinical trials managed by the US National… (More)
  • figure 1
  • table 1
  • table 2
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has been shown to benefit patients with… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND We conducted a multinational, randomized study to compare radiotherapy alone with radiotherapy plus cetuximab, a… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?